Wealth Alliance Sells 205 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Wealth Alliance lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 5.1% during the fourth quarter, Holdings Channel reports. The firm owned 3,849 shares of the medical device company’s stock after selling 205 shares during the period. Wealth Alliance’s holdings in Cooper Companies were worth $354,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Ashton Thomas Securities LLC acquired a new stake in Cooper Companies in the third quarter valued at about $25,000. Covestor Ltd boosted its stake in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares in the last quarter. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the fourth quarter valued at about $33,000. Brown Brothers Harriman & Co. boosted its stake in Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after buying an additional 275 shares in the last quarter. Finally, Cromwell Holdings LLC acquired a new stake in Cooper Companies in the third quarter valued at about $52,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of COO opened at $88.48 on Friday. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market capitalization of $17.66 billion, a price-to-earnings ratio of 45.37, a price-to-earnings-growth ratio of 2.19 and a beta of 1.00. The business has a 50-day moving average of $92.94 and a 200-day moving average of $99.55.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period last year, the company earned $0.87 earnings per share. The firm’s revenue was up 9.8% compared to the same quarter last year. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on COO. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup cut their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Finally, Wells Fargo & Company lifted their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.